Table 4.
Factor tested | Patient group | Total N | Mean survival (±SE) | 95% C.I. | χ2 | Log Rank test (Mantel-Cox) |
---|---|---|---|---|---|---|
| ||||||
Number of primary tumors | OPC | 42,314 | 111±1 months | 109–113 months | 691.4 | P<0.001 |
SPC | 5,769 | 151±2 months | 147–155 months | |||
Age at diagnosis of RCC | <60 years | 20,243 | 173±1.7 months | 170–176 months | 4,007.7 | P<0.001 |
≥60 years | 37,931 | 76±0.6 months | 74.6–77 months | |||
Race | White | 49,317 | 110±0.8 months | 108–111 months | 18.3 | P<0.001 |
Black | 5,903 | 106±2.5 months | 101–111 months | |||
Others | 2,761 | 115±3.5 months | 108.5–122 months | |||
Gender | Male | 36,630 | 104±1 months | 102–106 months | 75.7 | P<0.001 |
Female | 21,544 | 119.5±1.4 months | 117–122 months | |||
Marital status at time of diagnosis of RCC | Married | 36,410 | 121±1 months | 119–123 months | 1562.0 | P<0.001 |
Widowed | 8,754 | 62±1.2 months | 60–64 months | |||
Divorced | 4,307 | 103±2.6 months | 118–130 months | |||
Single | 5,955 | 124±3 months | 118–129.5 months | |||
Separated | 590 | 91±5.6 months | 80–102 months | |||
Summary stage (2004+) | Localized | 15,112 | 81±0.4 months | 80.5–82 months | 14,845.0 | P<0.001 |
Regional spread | 3,966 | 58.5±0.8 months | 57–55 months | |||
Distant spread | 6,328 | 13±0.3 months | 12–14 months | |||
Grade of RCC | Well differentiated | 4,911 | 179±3.5 months | 172–186 months | 2385.0 | P<0.001 |
Moderately differentiated | 10,631 | 154±2.9 months | 148–159 months | |||
Poorly differentiated | 5,882 | 98.5±3 months | 93–104 months | |||
Undifferentiated | 1,591 | 67±3.8 months | 59.5–74 months | |||
Size of tumor | ≤5cm | 12,948 | 124±1 months | 122–126 months | 1955.3 | P<0.001 |
>5cm-≤10cm | 13,410 | 97±0.9 months | 96–99 months | |||
>10cm | 5,561 | 66±1.2 months | 63–68 months | |||
Unilateral or Bilateral RCC | Unilateral | 56,308 | 113±0.8 months | 111–114 months | 3052.3 | P<0.001 |
Bilateral | 1,866 | 22±1.6 months | 19–25 months | |||
Radiation therapy given? | Yesc | 4,898 | 26±1 months | 24–27 months | 5057.4 | P<0.001 |
No | 52,214 | 119±0.9 months | 117–121 months | |||
Radiation sequence with surgery | Received both | 2,092 | 45±1.8 months | 41.5–49 months | 727.3 | P<0.001 |
Received neither | 56,078 | 113±0.8 months | 111–114 months |
Number of patients (N), only primary cancer (OPC), Secondary primary cancer (SPC), Well differentiated (WD), moderately differentiated (MD), poorly differentiated (PD),
Black, American Indian, Alaskan Native, Asian, Pacific islander
Regional or distant spread of tumor
Received either radiation or radioisotope therapy